| (Values in U.S. Thousands) | Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 |
| Sales | 180 | 210 | 170 | 130 | 120 |
| Sales Growth | -14.29% | +23.53% | +30.77% | +8.33% | +100.00% |
| Net Income | -130 | -260 | -250 | -680 | -440 |
| Net Income Growth | +50.00% | -4.00% | +63.24% | -54.55% | -120.00% |
Manuka Inc (MNKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
MANUKA INC. is a biopharmaceutical company. It develops treatments for serious and life-threatening infections which includes cytomegalovirus and malaria. MANUKA INC., formerly known as Artemis Therapeutics Inc., is based in New York.
Fiscal Year End Date: 12/31